67 related articles for article (PubMed ID: 4296726)
1. Genetic changes in attenuated poliovirus strains cultivated on human intestine in vitro.
Fogel A; Plotkin SA
Am J Epidemiol; 1968 Mar; 87(2):385-95. PubMed ID: 4296726
[No Abstract] [Full Text] [Related]
2. Differential sensitivity of virulent and attenuated strains of type 1 poliovirus to polyethylene glycol as a possible new genetic marker.
Lokteva VF; Chumakov MP; Zhevandrova VI; Shekoyan LA
Arch Gesamte Virusforsch; 1973; 41(3):155-9. PubMed ID: 4353792
[No Abstract] [Full Text] [Related]
3. Studies on characteristics of poliovirus. 3. Investigation of d, rct, h and n markers of poliovirus isolated after vaccination with the Type 1, Chat strain.
Böttiger M
Arch Gesamte Virusforsch; 1966; 18(2):135-54. PubMed ID: 4293025
[No Abstract] [Full Text] [Related]
4. Studies on characteristics of poliovirus. II. Plaque-forming capacity of attenuated poliovirus strains in human and monkey kidney cell cultures.
Böttiger M
Arch Gesamte Virusforsch; 1966; 18(2):127-34. PubMed ID: 4293024
[No Abstract] [Full Text] [Related]
5. Problems associated with the study of spontaneous mutation towards guanidine resistance in poliovirus.
Aubert-Combiescu A; Sergiescu D
Prog Immunobiol Stand; 1967; 3():82-3. PubMed ID: 4314441
[No Abstract] [Full Text] [Related]
6. Viral synthesis after simultaneous infection with guanidine-sensitive and guanidine-dependent polioviruses.
Loddo B; La Colla P; Mazzucato P; Maxia L; Tagliamonte A
Life Sci; 1969 Dec; 8(24):1261-71. PubMed ID: 4312126
[No Abstract] [Full Text] [Related]
7. The specific effectors of viral development.
Lwoff A
Biochem J; 1965 Aug; 96(2):289-301. PubMed ID: 4284431
[No Abstract] [Full Text] [Related]
8. Studies on characteristics of poliovirus. I. Marker and temperature.
Böttiger M
Arch Gesamte Virusforsch; 1966; 18(2):119-26. PubMed ID: 4293703
[No Abstract] [Full Text] [Related]
9. Distinctive features and comparative value of the genetic markers defining the behaviour of poliovirus towards different selective inhibitors.
Horodniceanu F; Sergiescu D; Aubert-Combiescu A; Crainic R
Prog Immunobiol Stand; 1967; 3():78-81. PubMed ID: 4314440
[No Abstract] [Full Text] [Related]
10. Double drug-dependence in a poliovirus strain.
Marcialis MA; La Colla P; Sirigu F; Loddo B
Ann Inst Pasteur (Paris); 1972 Oct; 123(4):613-5. PubMed ID: 4348600
[No Abstract] [Full Text] [Related]
11. Growth of viruses in organ cultures of intestine.
Rubenstein D; Tyrrell DA
Br J Exp Pathol; 1970 Apr; 51(2):210-6. PubMed ID: 4316099
[TBL] [Abstract][Full Text] [Related]
12. A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.
Vonka V; Janda Z; Simon J; Adam E; Stárek M
Prog Med Virol; 1967; 9():204-55. PubMed ID: 4293687
[No Abstract] [Full Text] [Related]
13. [Study of the nature of the S-marker of poliovirus].
Gendon IuZ; Romanova NM
Vopr Virusol; 1965; 10(1):41-6. PubMed ID: 4286091
[No Abstract] [Full Text] [Related]
14. Investigation of some possibilities of producing type 3 vaccine poliovirus with greater genetic stability. I. Preliminary experiments with passage variants.
Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV
Acta Virol; 1968 May; 12(3):193-202. PubMed ID: 4385148
[No Abstract] [Full Text] [Related]
15. Behavior of poliovirus towards dextran sulphate and relationship between this character and other genetic markers.
Sergiescu D; Horodniceanu F; Crainic R
Arch Roum Pathol Exp Microbiol; 1967 Jun; 26(2):453-63. PubMed ID: 4298003
[No Abstract] [Full Text] [Related]
16. Genetic transfer of guanidine resistance from type 2 to type 1 poliovirus.
Sergiescu D; Horodniceanu F; Klein R; Crainic R
Arch Gesamte Virusforsch; 1966; 18(2):231-43. PubMed ID: 4293028
[No Abstract] [Full Text] [Related]
17. [Antagonistic activity of some amino acids on guanidine inhibition of in vitro development of the poliovirus].
Loddo B; Schivo ML
Boll Soc Ital Biol Sper; 1965 Aug; 41(16):960-4. PubMed ID: 4286488
[No Abstract] [Full Text] [Related]
18. [Viral synthesis in cells infected simultaneously with guanidine sensitive and guanidine dependent poliovirus].
Mazzucato P; Tagliamonte A; Molle A; Loddo B
Riv Ist Sieroter Ital; 1968; 43(2):73-81. PubMed ID: 4301113
[No Abstract] [Full Text] [Related]
19. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
[TBL] [Abstract][Full Text] [Related]
20. Proceedings: Factors affecting transfer of antibiotic resistance between gram-negative bacteria in the human intestine.
Anderson JD
J Clin Pathol; 1973 Dec; 26(12):985. PubMed ID: 4784513
[No Abstract] [Full Text] [Related]
[Next] [New Search]